Literature DB >> 29999170

Distribution of bile acid receptor TGR5 in the gastrointestinal tract of dogs.

Paula R Giaretta1, Jan S Suchodolski2, Anna K Blick3, Joerg M Steiner2, Jonathan A Lidbury2, Raquel R Rech3.   

Abstract

Takeda-G-protein-receptor-5 (TGR5) is a receptor for bile acids and its expression has been described in a variety of tissues and species. Characterization of TGR5 distribution and function has been investigated in drug discovery for the treatment of metabolic diseases in humans. Because dogs are one of the species used in biomedical research and share some similarities with human gastrointestinal diseases, the objective of this study was to characterize the distribution of TGR5 receptor in the canine species. This study characterizes the distribution of TGR5 receptor in the gastrointestinal tract, liver, gallbladder, and pancreas of 8 dogs. The distribution of TGR5 antigen and mRNA expression was investigated using immunohistochemistry and RNA in situ hybridization, respectively. TGR5 immunolabeling was located in the cell membrane or in the cell membrane and cytoplasm. TGR5 immunolabeling was broadly distributed in macrophages, endothelial cells, ganglion cells, and leiomyocytes throughout all the examined tissues. Epithelial cells from tongue, stomach to rectum, as well as from gallbladder, biliary and pancreatic ducts demonstrated TGR5 immunolabeling. In endocrine cells, TGR5 immunolabeling was observed in intestinal enteroendocrine cells and islets of Langerhans in the pancreas. The hepatocytes had a unique pattern of immunolabeling located on the canalicular surface of the cell membrane. TGR5 mRNA expression was located mainly in the nucleus and the only negative cells throughout all examined tissues were striated muscle from tongue and esophagus, muscularis mucosae, esophageal glands, and hepatic sinusoids. These findings indicate that the bile acid receptor TGR5 is ubiquitously distributed in the canine gastrointestinal tract.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29999170     DOI: 10.14670/HH-18-025

Source DB:  PubMed          Journal:  Histol Histopathol        ISSN: 0213-3911            Impact factor:   2.303


  6 in total

Review 1.  Rethinking Bile Acid Metabolism and Signaling for Type 2 Diabetes Treatment.

Authors:  Karolina E Zaborska; Bethany P Cummings
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

2.  Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Authors:  Stephen J Keely; Andreacarola Urso; Alexandr V Ilyaskin; Christoph Korbmacher; Nigel W Bunnett; Daniel P Poole; Simona E Carbone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-10       Impact factor: 4.052

3.  Compound 18 Improves Glucose Tolerance in a Hepatocyte TGR5-dependent Manner in Mice.

Authors:  Marlena M Holter; Margot K Chirikjian; Daniel A Briere; Adriano Maida; Kyle W Sloop; Kristina Schoonjans; Bethany P Cummings
Journal:  Nutrients       Date:  2020-07-17       Impact factor: 5.717

Review 4.  Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1.

Authors:  Silvano Paternoster; Marco Falasca
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-11       Impact factor: 5.555

Review 5.  The gut microbiota to the brain axis in the metabolic control.

Authors:  Estelle Grasset; Remy Burcelin
Journal:  Rev Endocr Metab Disord       Date:  2019-12       Impact factor: 6.514

Review 6.  TGR5 Signaling in Hepatic Metabolic Health.

Authors:  Marlena M Holter; Margot K Chirikjian; Viraj N Govani; Bethany P Cummings
Journal:  Nutrients       Date:  2020-08-26       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.